-
-
-
-
-
-
-
ARIAD Pharma (ARIA) Investor Event with Management: Steady Upside Likely to Continue - Jefferies
-
-
-
-
-
-
-
Jeffereis Comments on Ariad Pharmaceuticals, Inc. (ARIA) Following ASCO Abstracts
-
-
-
-
-
-
-
ARIAD Pharmaceuticals (ARIA) PT Lifted to $4 at Jefferies
-
-
-
-
-
-
-
Jefferies Likes Early Iclusig Sales Data for ARIAD Pharmaceuticals (ARIA)
-
-
-
-
-
-
-
Jefferies Maintains Bullish View on ARIAD (ARIA) Despite CRL
-
-
-
-
-
-
-
Ph3 Ridaforolimus Data for Sarcoma in 1Q11, Jefferies Raises Price Target on ARIAD Pharmaceuticals (ARIA)
-
-
-
-
-
-
56,417 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All